These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 26653217
1. Putative suppressing effect of IgG Fc-conjugated haemagglutinin (HA) stalk of influenza virus H7N9 on the neutralizing immunogenicity of Fc-conjugated HA head: implication for rational design of HA-based influenza vaccines. He B, Xia S, Yu F, Fu Y, Li W, Wang Q, Lu L, Jiang S. J Gen Virol; 2016 Feb; 97(2):327-333. PubMed ID: 26653217 [Abstract] [Full Text] [Related]
5. Induction of neutralizing antibodies to influenza A virus H7N9 by inactivated whole virus in mice and nonhuman primates. Pan W, Han L, Dong Z, Niu X, Li Z, Bao L, Li C, Luo Q, Yang Z, Li X, Huang J, Feng L, Qin C, Zhong N, Chen L. Antiviral Res; 2014 Jul; 107():1-5. PubMed ID: 24746458 [Abstract] [Full Text] [Related]
6. Mutations in the Hemagglutinin Stalk Domain Do Not Permit Escape from a Protective, Stalk-Based Vaccine-Induced Immune Response in the Mouse Model. Roubidoux EK, Carreño JM, McMahon M, Jiang K, van Bakel H, Wilson P, Krammer F. mBio; 2021 Feb 16; 12(1):. PubMed ID: 33593972 [Abstract] [Full Text] [Related]
8. Recombinant influenza A virus hemagglutinin HA2 subunit protects mice against influenza A(H7N9) virus infection. To KK, Zhang AJ, Chan AS, Li C, Cai JP, Lau CC, Li CG, Jahan AS, Wu WL, Li L, Tsang AK, Chan KH, Chen H, Yuen KY. Arch Virol; 2015 Mar 16; 160(3):777-86. PubMed ID: 25616843 [Abstract] [Full Text] [Related]
9. Intranasal vaccination of recombinant H5N1 HA1 proteins fused with foldon and Fc induces strong mucosal immune responses with neutralizing activity: Implication for developing novel mucosal influenza vaccines. Yu F, Li Y, Guo Y, Wang L, Yang J, Zhao G, Zhou Y, Du L, Jiang S. Hum Vaccin Immunother; 2015 Mar 16; 11(12):2831-8. PubMed ID: 26260706 [Abstract] [Full Text] [Related]
10. Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses. Zhang L, Jia N, Li J, Han Y, Cao W, Wang S, Huang Z, Lu S. Hum Vaccin Immunother; 2014 Mar 16; 10(7):1949-58. PubMed ID: 25424804 [Abstract] [Full Text] [Related]
15. The optimized fusion protein HA1-2-FliCΔD2D3 promotes mixed Th1/Th2 immune responses to influenza H7N9 with low induction of systemic proinflammatory cytokines in mice. Song L, Xiong D, Kang X, Jiao Y, Zhou X, Wu K, Zhou Y, Jiao X, Pan Z. Antiviral Res; 2019 Jan 16; 161():10-19. PubMed ID: 30389471 [Abstract] [Full Text] [Related]
19. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses. Kwon HI, Kim YI, Park SJ, Song MS, Kim EH, Kim SM, Si YJ, Lee IW, Song BM, Lee YJ, Yun SJ, Kim WJ, Choi YK. J Virol; 2017 Jun 01; 91(11):. PubMed ID: 28331080 [Abstract] [Full Text] [Related]
20. Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection. Henry Dunand CJ, Leon PE, Huang M, Choi A, Chromikova V, Ho IY, Tan GS, Cruz J, Hirsh A, Zheng NY, Mullarkey CE, Ennis FA, Terajima M, Treanor JJ, Topham DJ, Subbarao K, Palese P, Krammer F, Wilson PC. Cell Host Microbe; 2016 Jun 08; 19(6):800-13. PubMed ID: 27281570 [Abstract] [Full Text] [Related] Page: [Next] [New Search]